• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不同粪菌移植方式治疗溃疡性结肠炎的临床缓解效果:一项荟萃分析。

Clinical remission of ulcerative colitis after different modes of faecal microbiota transplantation: a meta-analysis.

机构信息

Shaanxi University of Chinese Medicine, Xianyang, Shaanxi, China.

Affiliated Hospital of Shaanxi University of Chinese Medicine, Xianyang, Shaanxi, China.

出版信息

Int J Colorectal Dis. 2020 Jun;35(6):1025-1034. doi: 10.1007/s00384-020-03599-7. Epub 2020 May 9.

DOI:10.1007/s00384-020-03599-7
PMID:32388604
Abstract

BACKGROUND

Ulcerative colitis (UC) is a chronic, recurrent and destructive disease of the gastrointestinal tract. Faecal microbiota transplantation (FMT) is a therapeutic measure in which faecal microbiota from healthy people is transplanted into patients.

AIM

To systematically evaluate the safety and effectiveness of treating UC with different modes of FMT.

METHODS

Seven databases were searched by two independent researchers and studies related to randomized controlled trials were included in the analysis.

RESULTS

Seven studies on UC involving 431 patients were included in the analysis. The results showed that FMT had better efficacy than placebo (OR = 2.29, 95% CI 1.48-3.53, P = 0.0002). Subgroup analyses of influencing factors showed that frozen faeces from multiple donors delivered via the lower gastrointestinal tract had a better curative effect than placebo (OR = 2.76, 95% CI 1.59-4.79, P = 0.0003; OR = 2.93, 95% CI 1.67-5.71, P = 0.0002; and OR = 2.70, 95% CI 1.67-4.37, P < 0.0001); the difference in efficacy between mixed faeces from a single donor transplanted through the upper gastrointestinal tract and placebo was not significant(P = 0.05, P = 0.09 and P = 0.98). The analysis of side effects showed no significant difference between FMT and placebo (P = 0.43).

CONCLUSIONS

It may be safe and effective to transplant frozen faeces from multiple donors through the lower gastrointestinal tract to treat UC.

摘要

背景

溃疡性结肠炎(UC)是一种慢性、复发性和破坏性的胃肠道疾病。粪便微生物群移植(FMT)是一种治疗措施,即将健康人的粪便微生物群移植到患者体内。

目的

系统评价不同方式的 FMT 治疗 UC 的安全性和有效性。

方法

两名独立研究员检索了 7 个数据库,并纳入了与随机对照试验相关的研究进行分析。

结果

纳入了 7 项关于 UC 的研究,涉及 431 名患者。结果表明,FMT 比安慰剂更有效(OR=2.29,95%CI 1.48-3.53,P=0.0002)。影响因素的亚组分析表明,来自多个供体的冷冻粪便通过下消化道给药比安慰剂有更好的疗效(OR=2.76,95%CI 1.59-4.79,P=0.0003;OR=2.93,95%CI 1.67-5.71,P=0.0002;OR=2.70,95%CI 1.67-4.37,P<0.0001);来自单个供体的混合粪便通过上消化道移植与安慰剂的疗效差异无统计学意义(P=0.05,P=0.09 和 P=0.98)。不良反应分析显示,FMT 与安慰剂之间无显著差异(P=0.43)。

结论

通过下消化道移植来自多个供体的冷冻粪便可能是安全有效的 UC 治疗方法。

相似文献

1
Clinical remission of ulcerative colitis after different modes of faecal microbiota transplantation: a meta-analysis.不同粪菌移植方式治疗溃疡性结肠炎的临床缓解效果:一项荟萃分析。
Int J Colorectal Dis. 2020 Jun;35(6):1025-1034. doi: 10.1007/s00384-020-03599-7. Epub 2020 May 9.
2
Efficacy and safety of fecal microbiota transplantation for treating patients with ulcerative colitis: A systematic review and meta-analysis.粪便微生物群移植治疗溃疡性结肠炎患者的疗效和安全性:系统评价和荟萃分析。
J Dig Dis. 2020 Oct;21(10):534-548. doi: 10.1111/1751-2980.12933.
3
Faecal Microbiota Transplantation Engraftment After Budesonide or Placebo in Patients With Active Ulcerative Colitis Using Pre-selected Donors: A Randomized Pilot Study.使用预先筛选供体的在溃疡性结肠炎活动期患者中使用布地奈德或安慰剂后的粪便微生物群移植定植:一项随机先导研究。
J Crohns Colitis. 2024 Sep 3;18(9):1381-1393. doi: 10.1093/ecco-jcc/jjae043.
4
Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial.多供体强化粪菌移植治疗活动期溃疡性结肠炎:一项随机安慰剂对照试验。
Lancet. 2017 Mar 25;389(10075):1218-1228. doi: 10.1016/S0140-6736(17)30182-4. Epub 2017 Feb 15.
5
Efficacy of Fecal Microbiota Transplantation in the Treatment of Active Ulcerative Colitis: A Systematic Review and Meta-Analysis of Double-Blind Randomized Controlled Trials.粪便微生物群移植治疗活动性溃疡性结肠炎的疗效:双盲随机对照试验的系统评价和荟萃分析
Inflamm Bowel Dis. 2023 May 2;29(5):808-817. doi: 10.1093/ibd/izac135.
6
Systematic review with meta-analysis: faecal microbiota transplantation for the induction of remission for active ulcerative colitis.系统评价与荟萃分析:粪便微生物群移植诱导活动性溃疡性结肠炎缓解的研究
Aliment Pharmacol Ther. 2017 Aug;46(3):213-224. doi: 10.1111/apt.14173. Epub 2017 Jun 14.
7
[Fecal microbiota transplantation for the treatment of ulcerative colitis: a Meta-analysis].粪菌移植治疗溃疡性结肠炎:一项Meta分析
Zhonghua Nei Ke Za Zhi. 2019 Mar 1;58(3):202-208. doi: 10.3760/cma.j.issn.0578-1426.2019.03.010.
8
STOP-Colitis pilot trial protocol: a prospective, open-label, randomised pilot study to assess two possible routes of faecal microbiota transplant delivery in patients with ulcerative colitis.STOP-结肠炎试点试验方案:一项前瞻性、开放标签、随机试点研究,旨在评估溃疡性结肠炎患者粪便微生物群移植的两种可能给药途径。
BMJ Open. 2019 Nov 11;9(11):e030659. doi: 10.1136/bmjopen-2019-030659.
9
Fecal Microbiota Transplantation for Ulcerative Colitis: A Systematic Review and Meta-Analysis.粪便微生物群移植治疗溃疡性结肠炎:一项系统评价与荟萃分析。
PLoS One. 2016 Jun 13;11(6):e0157259. doi: 10.1371/journal.pone.0157259. eCollection 2016.
10
Lyophilised oral faecal microbiota transplantation for ulcerative colitis (LOTUS): a randomised, double-blind, placebo-controlled trial.冻干口服粪便微生物群移植治疗溃疡性结肠炎(LOTUS):一项随机、双盲、安慰剂对照试验。
Lancet Gastroenterol Hepatol. 2022 Feb;7(2):141-151. doi: 10.1016/S2468-1253(21)00400-3. Epub 2021 Dec 2.

引用本文的文献

1
Efficacy of different modalities of faecal microbiota transplantation in ulcerative colitis: systematic review and network meta-analysis.不同方式的粪便微生物群移植治疗溃疡性结肠炎的疗效:系统评价和网状Meta分析
Therap Adv Gastroenterol. 2025 Aug 25;18:17562848251369624. doi: 10.1177/17562848251369624. eCollection 2025.
2
Gut microbiota dysbiosis in inflammatory bowel disease: interaction with intestinal barriers and microbiota-targeted treatment options.炎症性肠病中的肠道微生物群失调:与肠道屏障的相互作用及针对微生物群的治疗选择
Front Cell Infect Microbiol. 2025 Jun 27;15:1608025. doi: 10.3389/fcimb.2025.1608025. eCollection 2025.
3
Fecal microbiota transplantation: application scenarios, efficacy prediction, and factors impacting donor-recipient interplay.
粪便微生物群移植:应用场景、疗效预测及影响供体-受体相互作用的因素
Front Microbiol. 2025 Mar 25;16:1556827. doi: 10.3389/fmicb.2025.1556827. eCollection 2025.
4
Exploring the Gut Microbiome's Role in Inflammatory Bowel Disease: Insights and Interventions.探索肠道微生物群在炎症性肠病中的作用:见解与干预措施。
J Pers Med. 2024 May 11;14(5):507. doi: 10.3390/jpm14050507.
5
Fecal microbiota transplantation as a therapy for treating ulcerative colitis: an overview of systematic reviews.粪便微生物群移植治疗溃疡性结肠炎:系统评价综述
BMC Microbiol. 2023 Nov 29;23(1):371. doi: 10.1186/s12866-023-03107-1.
6
The gut microbiome dysbiosis and regulation by fecal microbiota transplantation: umbrella review.肠道微生物群失调与粪便微生物群移植的调节:伞状综述
Front Microbiol. 2023 Nov 3;14:1286429. doi: 10.3389/fmicb.2023.1286429. eCollection 2023.
7
Research trends in ulcerative colitis: A bibliometric and visualized study from 2011 to 2021.溃疡性结肠炎的研究趋势:2011年至2021年的文献计量学与可视化研究
Front Pharmacol. 2022 Sep 9;13:951004. doi: 10.3389/fphar.2022.951004. eCollection 2022.
8
Update on gut microbiota in gastrointestinal diseases.胃肠道疾病中肠道微生物群的最新进展。
World J Clin Cases. 2022 Aug 6;10(22):7653-7664. doi: 10.12998/wjcc.v10.i22.7653.
9
Kui Jie Tong Ameliorates Ulcerative Colitis by Regulating Gut Microbiota and NLRP3/Caspase-1 Classical Pyroptosis Signaling Pathway.奎杰痛安通过调节肠道微生物群和 NLRP3/Caspase-1 经典焦亡信号通路改善溃疡性结肠炎。
Dis Markers. 2022 Jul 4;2022:2782112. doi: 10.1155/2022/2782112. eCollection 2022.
10
Fecal Microbiota Transplantation and Health Outcomes: An Umbrella Review of Meta-Analyses of Randomized Controlled Trials.粪便微生物群移植与健康结局:随机对照试验荟萃分析的伞状评价。
Front Cell Infect Microbiol. 2022 Jun 27;12:899845. doi: 10.3389/fcimb.2022.899845. eCollection 2022.